We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+20.77%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$547M
Cap. Flow
+$491M
Cap. Flow %
48%
Top 10 Hldgs %
88.16%
Holding
123
New
24
Increased
19
Reduced
32
Closed
28

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$4.7M
2
ZGNX
Zogenix, Inc.
ZGNX
+$3.17M
3
WNC icon
Wabash National
WNC
+$1.87M
4
SAGE
Sage Therapeutics
SAGE
+$1.75M
5
PRTA icon
Prothena Corp
PRTA
+$1.53M

Top Sells

Rank Stock Value
1
HIMX
Himax Technologies
HIMX
+$4.17M
2
MB
MINDBODY, Inc. Class A Common Stock
MB
+$2.9M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.74M
4
AMD icon
Advanced Micro Devices
AMD
+$2.52M
5
MYND
Mynd.ai
MYND
+$2.28M

Sector Composition

Rank Sector Weight
1 Healthcare 5.08%
2 Technology 2.88%
3 Communication Services 2.01%
4 Consumer Discretionary 1.64%
5 Industrials 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXON
26
Axon Enterprise
AXON
$42.5B
$2.15M 0.21%
81,200
+30,000
+59% +$720K
JOYY
27
JOYY Inc
JOYY
$3.71B
$2.03M 0.2%
17,984
-400
-2% -$40.1K
EVBG
28
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2M 0.2%
67,450
-8,300
-11% -$226K
HIMX
29
CALL
Himax Technologies
HIMX
$2.19B
$1.96M 0.19%
188,500
-1,300,000
-87% -$14.1M
WNC icon
30
Wabash National
WNC
$512M
$1.95M 0.19%
+90,000
New +$1.87M
NVRO
31
DELISTED
NEVRO CORP.
NVRO
$1.88M 0.18%
27,200
-900
-3% -$72K
AMZN icon
32
Amazon
AMZN
$2.92T
$1.87M 0.18%
32,000
-4,000
-11% -$220K
BMY icon
33
Bristol-Myers Squibb
BMY
$133B
$1.84M 0.18%
30,000
– –
GTLS
34
DELISTED
Chart Industries
GTLS
$1.79M 0.18%
38,200
-6,800
-15% -$303K
FPRX
35
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.75M 0.17%
80,000
+30,000
+60% +$965K
BAC icon
36
Bank of America
BAC
$435B
$1.7M 0.17%
57,600
-6,200
-10% -$171K
KRNT icon
37
Kornit Digital
KRNT
$705M
$1.58M 0.15%
98,000
+18,000
+23% +$284K
EDU icon
38
New Oriental
EDU
$9.37B
$1.58M 0.15%
16,800
+600
+4% +$53.3K
TAL icon
39
TAL Education Group
TAL
$6.93B
$1.52M 0.15%
51,100
-4,500
-8% -$137K
AXTI icon
40
AXT Inc
AXTI
$3.95B
$1.5M 0.15%
172,000
+130,000
+310% +$1.19M
CLLS
41
Cellectis
CLLS
$277M
$1.46M 0.14%
+50,000
New +$1.36M
CI icon
42
Cigna
CI
$73.7B
$1.42M 0.14%
7,000
– –
CDNA icon
43
CareDx
CDNA
$2.26B
$1.4M 0.14%
+190,000
New +$1.18M
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
$1.36M 0.13%
20,000
-10,700
-35% -$748K
BFYT
45
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$1.26M 0.12%
50,500
+20,600
+69% +$460K
ZYNE
46
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.25M 0.12%
100,000
-100,000
-50% -$1.15M
EVH icon
47
Evolent Health
EVH
$348M
$1.23M 0.12%
100,000
+50,000
+100% +$705K
DIN icon
48
Dine Brands
DIN
$456M
$1.19M 0.12%
23,400
-4,100
-15% -$191K
AAPL icon
49
Apple
AAPL
$4.54T
$1.15M 0.11%
27,200
– –
PRTA icon
50
Prothena Corp
PRTA
$425M
$1.13M 0.11%
+30,000
New +$1.53M
1
2
3 4 5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Granite Point Capital Management held 123 positions worth $1.02B, up 115% from $475M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Granite Point Capital Management deployed $491M of net new capital in Q4 2017, opening 24 new positions and adding to 19 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.

By sector, the portfolio is most concentrated in Healthcare at 5.1% of assets, down from 8.5% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Himax Technologies, an estimated $4.17M trimmed.

  • Granite Point Capital Management's largest Q4 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.
  • Granite Point Capital Management added most to Zogenix, Inc. in Q4 2017, an estimated $3.17M increase.
  • Granite Point Capital Management's biggest Q4 2017 reduction was Himax Technologies, cutting an estimated $4.17M.
  • Granite Point Capital Management fully exited MINDBODY, Inc. Class A Common Stock in Q4 2017, selling an estimated $2.9M.
  • Granite Point Capital Management's ten largest holdings make up 88% of its $1.02B portfolio in Q4 2017.
  • Granite Point Capital Management opened 24 new positions and closed 28 in Q4 2017.
  • Granite Point Capital Management's portfolio value rose 115% quarter-over-quarter to $1.02B.

Based on Granite Point Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.